Ablative Treatment of Inflammatory and Other Diseases With Monoclonal Antibodies (Mabs) or Janus Kinases (Nibs) Increases Risk for Infection
From the ∗AU/UGA Medical Partnership, Athens, GA
†NEOMED, Rootstown, OH.
Correspondence to: Ken S. Rosenthal, PhD, AU/UGA Medical Partnership, Russell Hall Rm 157, 1425 Prince Ave, Athens, GA 30602. E-mail: [email protected].
There are no additional acknowledgements or sources of support or disclosures of potential conflicts of interest.
Both authors provided equivalent authorship of this manuscript.
Comments (0)